Dance of the Pen versus Mandala activities to reduce anxiety during chemotherapy
Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients: A Randomized Controlled Study
This project will test whether a short 'Dance of the Pen' art session or mandala drawing can lower immediate anxiety in adults receiving chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Atlas University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT07435597 on ClinicalTrials.gov |
What this trial studies
This randomized, single-blind, two-group pre-test/post-test trial will enroll 60 adults receiving chemotherapy at two hospitals in Istanbul. Participants will be assigned by chemotherapy session day to either a single 30–60 minute 'Dance of the Pen' art session or a mandala activity, with measures taken before and after. Outcomes include state anxiety measured by the STAI-I, a Distress Thermometer, and participant satisfaction ratings. The study compares immediate changes in state anxiety and reports acceptability of each intervention.
Who should consider this trial
Good fit: Adults (18+) receiving chemotherapy who are literate, speak Turkish, able to consent, and do not have a current psychiatric diagnosis or use psychiatric medication are ideal candidates.
Not a fit: Patients with speech or comprehension impairments, current psychiatric diagnoses or psychiatric medication use, non-Turkish speakers, or those already enrolled in similar programs may not benefit or be eligible.
Why it matters
Potential benefit: If successful, these brief, low-cost activities could reduce short-term anxiety and distress during chemotherapy visits.
How similar studies have performed: Previous small and nonrandomized studies have suggested art and mandala activities can reduce anxiety, but randomized evidence is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be 18 years of age or older * Must be receiving chemotherapy treatment * Must be willing to participate in the research * Must be literate * Must be able to speak and understand Turkish Exclusion Criteria: * -Having any speech or comprehension impairment * Being treated with other forms of treatment * Having any accompanying psychiatric diagnosis * Using any psychiatric medication * Being enrolled in another program using a similar method could affect the study's outcome
Where this trial is running
Istanbul
- Basaksehir Cam Sakura Hospital — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Dilek Baykal, Associate Professor
- Email: dilek.baykal@atlas.edu.tr
- Phone: +902124443439
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.